Clinical Trials List
2014-01-01 - 2021-12-31
Phase III
Terminated9
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Hui-Jen Tsai Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- HSIN-AN HOU Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- 蔡偉 Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- 李啟誠 Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jin-Hwang Liu Division of Hematology & Oncology
- 曾成槐 Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- 劉俊宇 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Li-Yuan Bai Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 戴明燊 Division of Hematology & Oncology
- 高偉堯 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
450 participants
